Successful management of familial hemophagocytic lymphohistiocytosis by the JAK 1/2 inhibitor ruxolitinib.

Louis MaroisFabien TouzotElie HaddadIsabel FernandezMarie-Paule MorinJean Jacques De BruyckerMichel DuvalSonia CellotPierre TeiraHenrique BittencourtHélène Decaluwe

Published in: Pediatric blood & cancer (2021)

Keyphrases

early onset